Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
IRONWOOD PHARMACEUTICALS INC has filed 1,401 SEC EDGAR filings since 26 Sep 2008

SEC filing history

Showing 126-150 of 194 matching filings.

Per page
25
Current page
6
8-K File 001-34620

8-K

Filing date
03 Nov 2015
Reporting date
03 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
27 Oct 2015
Reporting date
26 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
05 Aug 2015
Reporting date
05 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
25 Jun 2015
Reporting date
22 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
15 Jun 2015
Reporting date
09 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
05 Jun 2015
Reporting date
03 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
05 May 2015
Reporting date
05 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
16 Apr 2015
Reporting date
13 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
12 Feb 2015
Reporting date
12 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
02 Sep 2014
Reporting date
27 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
04 Aug 2014
Reporting date
04 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
26 Jun 2014
Reporting date
23 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
09 Jun 2014
Reporting date
03 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
04 Aug 2014
Reporting date
04 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
26 Jun 2014
Reporting date
23 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
09 Jun 2014
Reporting date
03 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
04 Jun 2014
Reporting date
03 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
29 Apr 2014
Reporting date
29 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
18 Apr 2014
Reporting date
14 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
12 Feb 2014
Reporting date
06 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
12 Feb 2014
Reporting date
11 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
10 Feb 2014
Reporting date
10 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
21 Jan 2014
Reporting date
21 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
08 Jan 2014
Reporting date
08 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .